Hindustan Bio Sciences (BOM:532041) Altman Z2-Score: 1.75 (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532041 Hindustan Bio Sciences Ltd BOM:532041
51 GF Score
Price ₹7.12
GF Value ₹6.11
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Hindustan Bio Sciences Altman Z2-Score?

Hindustan Bio Sciences BOM:532041 -1.11% 51 Altman Z2-Score is 1.75 as of Aug. 04, 2026. GuruFocus rates BOM:532041 with a GF Score™ of 51/100 and a GF Value™ of ₹6.11 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 976 Drug Manufacturers companies, Hindustan Bio Sciences ranks worse than 68.34% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Hindustan Bio Sciences has a Altman Z2-Score of 1.75, indicating it is in Grey Zones. This implies that Hindustan Bio Sciences is in some kind of financial stress. If it is below 1.1, the company may face bankrupcy risk.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Hindustan Bio Sciences's Altman Z2-Score or its related term are showing as below:

BOM:532041' s Altman Z2-Score Range Over the Past 10 Years
Min: -12.41   Med: -2.44   Max: 1.75
Current: 1.75

During the past 13 years, Hindustan Bio Sciences's highest Altman Z2-Score was 1.75. The lowest was -12.41. And the median was -2.44.


Hindustan Bio Sciences  (BOM:532041) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Hindustan Bio Sciences Altman Z2-Score Related Terms


Hindustan Bio Sciences Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for Hindustan Bio Sciences's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hindustan Bio Sciences Altman Z2-Score Chart

Hindustan Bio Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.41 -2.17 1.05 1.63 1.75

Hindustan Bio Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.63 0.00 1.56 0.00 1.75

BOM:532041 vs ZTS: Altman Z2-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hindustan Bio Sciences's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hindustan Bio Sciences Altman Z2-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hindustan Bio Sciences's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Hindustan Bio Sciences's Altman Z2-Score falls into.


BOM:532041
51GF Score
Hindustan Bio Sciences Ltd BOM:532041
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hindustan Bio Sciences Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Hindustan Bio Sciences's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.2354+3.26*0+6.72*-0.0244+1.05*0.3486
=1.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2026:
Total Assets was ₹31.95 Mil.
Total Current Assets was ₹7.72 Mil.
Total Current Liabilities was ₹0.20 Mil.
Retained Earnings was ₹0.00 Mil.
Pre-Tax Income was -1.166 + 0.82 + -0.585 + 0.14 = ₹-0.79 Mil.
Interest Expense was 0 + -0.005 + -0.001 + -0.005 = ₹-0.01 Mil.
Total Liabilities was ₹23.69 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(7.721 - 0.199)/31.954
=0.2354

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-0.791 - -0.011)/31.954
=-0.0244

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(8.26 - 0)/23.694
=0.3486

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Hindustan Bio Sciences has a Altman Z2-Score of 1.75 indicating it is in Grey Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of 1.75 mean?
Hindustan Bio Sciences (BOM:532041) has a Altman Z2-Score of 1.75 as of Aug. 04, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Hindustan Bio Sciences and its competitors. According to the industry distribution chart, Hindustan Bio Sciences ranks #667 out of 976 companies in the Drug Manufacturers industry, placing it in the top 68.3%.
Is Hindustan Bio Sciences' Altman Z2-Score too high?
Hindustan Bio Sciences' current Altman Z2-Score is 1.75. The Drug Manufacturers industry median Altman Z2-Score is 3.79. Hindustan Bio Sciences' value of 1.75 is 53.8% below this industry median. Based on the distribution chart, Hindustan Bio Sciences ranks #667 out of 976 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Hindustan Bio Sciences has a GF Score™ of 51/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hindustan Bio Sciences' Altman Z2-Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Hindustan Bio Sciences ranks #667 out of 976 companies for Altman Z2-Score. This places Hindustan Bio Sciences in the lower half of its industry. The industry median Altman Z2-Score is 3.79. Hindustan Bio Sciences' value of 1.75 is 53.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Drug Manufacturers company?
The median Altman Z2-Score among Drug Manufacturers companies is 3.79, based on 976 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hindustan Bio Sciences's current Altman Z2-Score of 1.75 is 53.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Hindustan Bio Sciences and its competitors. For the Drug Manufacturers industry, the median Altman Z2-Score is 3.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hindustan Bio Sciences's current Altman Z2-Score is 1.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hindustan Bio Sciences stock overvalued right now?
Based on GuruFocus' analysis, Hindustan Bio Sciences (BOM:532041) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹6.11, compared to a current price of ₹7.12 — trading 16.5% above its estimated fair value. The current Altman Z2-Score is 1.75 and 53.8% below the Drug Manufacturers industry median of 3.79. Hindustan Bio Sciences' overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Hindustan Bio Sciences (BOM:532041), the current Altman Z2-Score is 1.75 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hindustan Bio Sciences (BOM:532041) Overvalued in 2026?

Based on GuruFocus' analysis, Hindustan Bio Sciences stock appears to be overvalued. The current stock price of ₹7.12 is trading 16.5% above its estimated GF Value™ of ₹6.11. GuruFocus considers Hindustan Bio Sciences to be Modestly Overvalued.

Key valuation signals for BOM:532041:

  • Altman Z2-Score: 1.75
  • GF Value™: ₹6.11 vs. price of ₹7.12 (16.5% above fair value)
  • GF Score™: 51/100 with 3 warning signs
  • Industry Position: 53.8% below the Drug Manufacturers median (#667 of 976)

No single metric tells the full story. See the BOM:532041 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hindustan Bio Sciences Business Description

Address Road No. 2, Banjara Hills, H.No. 8-2-269/S, Plot No. 31, Sagar Co-Operative Housing Society, Hyderabad, TG, IND, 500034
Hindustan Bio Sciences Ltd is an Indian pharmaceutical company, engaged in the manufacturing and sale of pharmaceutical products. The company manufactures and markets drugs and medicines in tablets, capsules, drops, externels, and syrup forms. Geographically, all of its revenue is generated through the export of its products to international markets.
51GF Score

Get the complete analysis for BOM:532041

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7.12
Price
₹6.11
GF Value